The European Chemicals Agency classified metolachlor as a suspected human carcinogen (Carcinogen category 2) in 2022. The
United States Environmental Protection Agency (US EPA) has classified Metolachlor as a Group C, possible human carcinogen, based on liver tumors in rats at the highest dose tested (HDT). Evidence of the
bioaccumulation of metolachlor in edible species of fish as well as its adverse effect on the growth and development has raised concerns on its effects on human and environmental health. For example, products with this active ingredient are restricted to professional licensed applicators in the U.S. state of Massachusetts. Though there is no set maximum concentration (
maximum contaminant level, MCL) for metolachlor that is allowed in drinking water, the US EPA does have a health advisory level (HAL) of 0.525 mg/L. Metolachlor has been detected in ground and surface waters in concentrations ranging from 0.08 to 4.5 parts per billion (ppb) throughout the U.S. Metolachlor induces
cytotoxic and
genotoxic effects in human lymphocytes. Genotoxic effects have also been observed in tadpoles exposed to metolachlor. Evidence also reveals that metolachlor affects cell growth. Cell division in yeast was reduced, and chicken embryos exposed to metolchlor showed a significant decrease in the average body mass compared to the control. ==See also==